{
    "1721459913795211687": {
        "attachments": {
            "media_keys": [
                "3_1721459911475757056"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-11-06T09:30:01.000Z",
        "edit_history_tweet_ids": [
            "1721459913795211687"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 24,
                    "normalized_text": "Transthyretin amyloidosis",
                    "probability": 0.6926,
                    "start": 0,
                    "type": "Other"
                },
                {
                    "end": 39,
                    "normalized_text": "polyneuropathy",
                    "probability": 0.5932,
                    "start": 26,
                    "type": "Other"
                },
                {
                    "end": 49,
                    "normalized_text": "PN",
                    "probability": 0.2895,
                    "start": 48,
                    "type": "Other"
                },
                {
                    "end": 66,
                    "normalized_text": "TTR",
                    "probability": 0.6704,
                    "start": 64,
                    "type": "Other"
                },
                {
                    "end": 248,
                    "normalized_text": "ATTRv",
                    "probability": 0.5229,
                    "start": 244,
                    "type": "Organization"
                }
            ],
            "urls": [
                {
                    "display_url": "learn.az/6019ulFtN",
                    "end": 277,
                    "expanded_url": "https://learn.az/6019ulFtN",
                    "start": 254,
                    "status": 200,
                    "unwound_url": "https://www.astrazeneca.com/media-centre/articles/2023/detecting-amyloidosis-understanding-the-different-types-of-attr.html?utm_source=twitter&utm_medium=evergreen+attr+campaign+-+q4+2023&utm_term=12105&utm_content=cvrm",
                    "url": "https://t.co/db7JNCWkdB"
                },
                {
                    "display_url": "pic.twitter.com/iapBvsgB1b",
                    "end": 301,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1721459913795211687/photo/1",
                    "media_key": "3_1721459911475757056",
                    "start": 278,
                    "url": "https://t.co/iapBvsgB1b"
                }
            ]
        },
        "id": "1721459913795211687",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 4988,
            "like_count": 20,
            "quote_count": 1,
            "reply_count": 0,
            "retweet_count": 3
        },
        "text": "Transthyretin amyloidosis-polyneuropathy (ATTRv-PN) occurs when TTR proteins misfold and build up in the peripheral nervous system. These misfolded proteins cause damage and can lead to motor disability. Learn more about improving outcomes for ATTRv-PN: https://t.co/db7JNCWkdB https://t.co/iapBvsgB1b"
    }
}